$2 billion vaccine deal with Pfizer raises pricing concerns

$2 billion vaccine deal with Pfizer raises pricing concerns
The Trump administration’s nearly $2 billion investment in Pfizer and a smaller German biotechnology company for a coronavirus vaccine is raising eyebrows among lawmakers and drug pricing advocates.The deal announced Wednesday is the largest yet for...

Source: https://ift.tt/2BnCoCa